Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New EGFR inhibitors discovered at Boehringer Ingelheim

Nov. 10, 2003

Good efficacy and safety profile reported for arzoxifene in hormone-sensitive breast cancer

Nov. 10, 2003

Troxacitabine safety and efficacy in CML-BP

Nov. 7, 2003

Oral topoisomerase I inhibitor added to Novartis pipeline

Nov. 7, 2003

Abbott researchers describe new protein kinase inhibitors, their preparation and use

Nov. 7, 2003

New antitumor compounds identified at Welichem

Nov. 7, 2003

Eisai patent covers new hemiasterlin analogues for cancer therapy

Nov. 7, 2003

YM BioSciences cleared to begin pivotal trial of tesmilifene

Nov. 6, 2003

Ark Therapeutics granted patent for EG-009

Nov. 6, 2003

Novartis scientists identify new steryl-sulfatase inhibitors

Nov. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...